Local News: Adana, Turkey 

 | 

Sign Up

 | 

Sign In

Genzyme General News Editors

News Widget

Display the Genzyme General news headlines on your website.

Get the Topix Headlines Widget

Share & bookmark

RSS icon mobile icon

Genzyme General News

News on Genzyme General (Ticker: SNY) continually updated from thousands of sources around the net.

24 min ago | BioSpace

California Healthcare Institute (CHI) Board Elects New Members

Dr. David Meeker, president and CEO of Cambridge, Mass.-based biotechnology company Genzyme Corp., a Sanofi company; Dr.

Comment?

Related Topix: Cambridge, MA, Biotech, Medicine, Healthcare Industry, Pfizer, Non-Profit, Ohio State University, University of Vermont

Wed Feb 08, 2012

Wall St. Cheat Sheet

Healthcare Business Recap: Amgen's Limitation, Sanofi's Earnings

Sanofi's fourth quarter income of Genzyme and emerging markets offsets the death of patents and the effect of European Union rigor.

Comment?

Related Topix: Biotech, SanofiSynthlabo, Medicine, Amgen, Healthcare Industry, GlaxoSmithKline

BioSpace

Sanofi (France): 2011 Results Benefit from Genzyme Corporation Acquisition

In order to facilitate an understanding of our operational performance, we comment on our business net income statement.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Financial Markets

Freshnews

Four-Year Data from Phase 2 Trial of Genzyme Gaucher Disease Oral...

Genzyme , a Sanofi company , announced today four-year follow-up data from patients enrolled in the phase 2 clinical trial for its investigational oral therapy for Gaucher disease type 1 known as eliglustat tartrate.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Cerezyme, Imiglucerase (generic), Medication, Genetics

Drugs.com

Sanofi and Bristol-Myers Squibb Collect Damages in Plavix Patent Litigation with Apotex

PARIS & NEW YORK-- --Feb 8, 2012 - Sanofi and Bristol-Myers Squibb Company announced today that Apotex has made payment in the amount of $442,209,362 to Sanofi and Bristol-Myers Squibb to satisfy the damages ruling of the Plavix patent infringement case against Apotex.

Comment?

Related Topix: Medarex, Financial Services, Banco SantanderChile, Biotech, Medicine, SanofiSynthlabo, Origin Healthcare Solutions, Acambis, Healthcare Industry

The Washington Post

Sanofi Sees 2012 Profit Falling as Much as 15% on Generics

Sanofi, France's biggest drugmaker, said profit may drop as much as 15 percent this year, hurt by generic competition to its Plavix blood-thinner and Avapro hypertension drug in the U.S. Earnings per share excluding some costs will probably decline between 12 percent and 15 percent at constant exchange rates, Paris-based Sanofi said in an e-mailed ... (more)

Comment?

Related Topix: Medicine, Hypertension, Health, Biotech, Healthcare Industry, Diabetes, Business News

Daily News

Drugmaker Sanofi reports quarterly earnings up, warns of patent loss impact on 2012 profit

Drugmaker Sanofi SA says its earnings rose in the fourth quarter thanks to its acquisition of U.S. biotechnology firm Genzyme as well as double-digit growth in its consumer healthcare, diabetes and emerging markets businesses.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Diabetes, Health, Lantus, Insulin Glargine (generic), Medication

Tue Feb 07, 2012

Business Journal

Radius Health looks to be next public Cambridge biotech

Michael Wyzga was CFO of Genzyme during its acquisition by Sanofi last April. He is now CEO of Radius Health, a Cambridge biotech seeking an IPO that focuses on osteoporosis and women's health.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Osteoporosis, Health, Women's Health

Mon Feb 06, 2012

PR-inside.com

Genzyme Corporation: Company Profile and SWOT Analysis - new company profile report published

The company develops and applies technologies to encounter unmet deadly diseases.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Genetics, Cambridge, MA

Wed Feb 01, 2012

BioSpace

Genzyme Corporation Hit With Layoffs as Sanofi (France) Integration Continues

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia Genzyme Corp.'s research and development operations in Massachusetts have been cut by an unspecified number of positions, according to parent company Sanofi .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Http

Genzyme Shakeup Will Keep Employee Count Level

Sanofi, the new owner of Cambridge research company Genzyme, which has major manufacturing operations in Framingham, today announced plans to lay off some of its employees.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Business Journal

Genzyme hit with layoffs as Sanofi integration continues

Genzyme Corp.'s research and development operations in Massachusetts have been cut by an unspecified number of positions, according to parent company Sanofi .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Bjp.rcpsych.org

Antibody-mediated encephalitis: a treatable cause of schizophrenia [EDITORIALS]

Correspondence : Belinda R. Lennox, DM, MRCPsych, Department of Psychiatry, University of Cambridge, Herchel Smith Building, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK.

Comment?

Related Topix: Medicine, Psychiatry, Biotech, Healthcare Industry

Tue Jan 31, 2012

Market Wire

Sobi: Wills Hughes-Wilson appointed Vice President Government Affairs & Policy

Wills Hughes-Wilson has been appointed Vice President, Government Affairs & Policy with responsibility for Sobi's contacts with all stakeholders in the health policy area.

Comment?

Related Topix: Biotech, Healthcare Industry

Mon Jan 30, 2012

Wall St. Cheat Sheet

Jim Cramer Stock Watch: Jan 27th Stock Picks

Suburban Propane Partners LP : Jim Cramer ranked this stock a Sell . The stock closed at $45.13, its 52-week high is $58.49, and its 52-week low is $40.25. Sanofi-Aventis : Jim Cramer ranked this stock a Buy .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Mad Money, Entertainment, Television, Retail, Suburban Propane Partners LP, Energy, Oil & Gas, SanofiSynthlabo, Startups, KLA Tencor, JC Penney

Thu Jan 26, 2012

Wall St. Cheat Sheet

Healthcare Sector Review: Amgen's M&A, Johnson & Johnson May Be Eyeing Elan

Amgen and Micromet announced that the companies have entered into a definitive merger agreement under which Amgen will acquire Micromet, a biotechnology company founded in Germany with its research and development center in Munich and headquarters in Rockville, Md., for $11 per share in cash.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Johnson and Johnson, Elan Corporation Plc, Amgen, Micromet

BioSpace

The Hotbed Driving Force in Biotech: Massachusetts

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia By Michelle Wong, BioSpace.com Massachusetts is picking up steam in the biotech industry while other states have been struggling to stay afloat in this tough economy.

Comment?

Related Topix: Biotech, Science / Technology, Startups, BioSpace.com, Medicine, Healthcare Industry, Massachusetts Institute of Technology, Cambridge, MA, Pfizer

BusinessWeek

Sanofi's Viehbacher Sees 'a Few Signs' of Recovery in Europe

Sanofi Chief Executive Officer Chris Viehbacher sees "a few signs" pointing to a recovery in Europe although it's too soon to tell whether the region's debt crisis may be approaching an end.

Comment?

Related Topix: Biotech, Healthcare Industry

Wed Jan 25, 2012

International Business Times

Genzyme's New Plant Gets FDA Approval to Manufacture Fabrazyme

French drug-maker Sanofi, which acquired Genzyme Corp, has announced that the Food and Drug Administrator has given approval to its new plant to manufacture Fabrazyme, a drug used for the treatment of Fabry disease.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Tue Jan 24, 2012

Reuters

French and Benelux stocks-Factors to watch on Jan 24

Below are company-related news and stories from French and Benelux media which could have an impact on the region's markets or individual stocks.

Comment?

Related Topix: Financial Markets, Biotech, Medicine, Healthcare Industry

Also on Topix